GlassScriptPhysician profile
Harathi Bandaru
NPI 1629229935
$7,514.47
in general payments reported to CMS, 2019-2025
53 companies · $1,651 in 2025
The $1,651 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2021: $408 · 2022: $1,801 · 2023: $2,631 · 2024: $917 · 2025: $1,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,183 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,183.08 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,645.47 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Acadia Pharmaceuticals INC | $538.37 | 2021-2025 | Nuplazid, Daybue |
| Novartis Pharmaceuticals Corporation | $427.86 | 2022-2025 | |
| Biogen, INC. | $409.33 | 2019-2025 | Tysabri, Vumerity |
| Ucb, INC. | $304.19 | 2022-2025 | Briviact, Fintepla, Rystiggo |
| Pfizer INC. | $251.81 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $234.08 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Genzyme Corporation | $233.70 | 2021-2025 | |
| Lilly USA, LLC | $229.43 | 2021-2025 | Kisunla, Emgality, Reyvow |
| Argenx US, INC. | $206.64 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Lundbeck LLC | $191.65 | 2022-2025 | Vyepti |
| Sk Life Science, INC. | $186.47 | 2022-2023 | Xcopri |
| Amneal Pharmaceuticals LLC | $184.21 | 2022-2025 | Rytary, Crexont |
| Emd Serono, INC. | $181.78 | 2022-2025 | Mavenclad |
| Supernus Pharmaceuticals, INC. | $172.08 | 2021-2022 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $161.92 | 2023-2025 | Gamunex-C |
| Medtronic, INC. | $157.89 | 2021-2025 | Percept PC Brainsense |
| Biohaven Pharmaceutical Holding Company LTD. | $142.30 | 2022 | |
| Neurelis, INC. | $129.01 | 2022-2025 | Valtoco |
| Sumitomo Pharma America, INC. | $111.68 | 2023 | Aptiom |
| Sunovion Pharmaceuticals INC. | $108.63 | 2021-2022 | |
| Catalyst Pharmaceuticals, INC. | $87.78 | 2023-2024 | Fycompa |
| Amgen INC. | $87.32 | 2021-2023 | Aimovig |
| Boston Scientific Corporation | $81.82 | 2022-2024 | |
| Impel Pharmaceuticals INC. | $74.64 | 2023 | Trudhesa |
| Abbott Laboratories | $74.38 | 2023 | Infinity |
| Ani Pharmaceuticals, INC. | $73.21 | 2025 | Purified Cortrophin Gel |
| Jazz Pharmaceuticals INC. | $68.12 | 2025 | |
| Neurocrine Biosciences, INC. | $63.38 | 2022-2025 | Ingrezza, Ongentys |
| Genentech USA, INC. | $56.98 | 2023-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Scilex Pharmaceuticals INC. | $53.37 | 2024-2025 | |
| Biohaven Pharmaceuticals, INC. | $47.72 | 2021 | |
| Eisai INC. | $42.16 | 2024-2025 | |
| Kyowa Kirin, INC. | $41.57 | 2024 | Nourianz |
| Otsuka America Pharmaceutical, INC. | $41.56 | 2025 | Rexulti |
| Nevro Corp. | $39.68 | 2022-2023 | Senza |
| Mallinckrodt Hospital Products INC. | $35.46 | 2024-2025 | Acthar |
| Microtransponder, INC. | $33.09 | 2025 | |
| Ge Healthcare | $30.99 | 2021-2022 | |
| Mdd US Operations, LLC | $28.67 | 2024 | Gocovri |
| Allergan, INC. | $28.28 | 2021 | |
| Tg Therapeutics, INC. | $23.60 | 2025 | |
| Janssen Biotech, INC. | $21.63 | 2025 | |
| Avion Pharmaceuticals | $19.57 | 2022 | |
| Azurity Pharmaceuticals, INC. | $19.40 | 2025 | |
| Hospira, INC. | $17.78 | 2025 | |
| Merz Pharmaceuticals, LLC | $17.40 | 2025 | Xeomin |
| Axsome Therapeutics, INC. | $16.65 | 2025 | Symbravo |
| Livanova USA, INC. | $16.61 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Celgene Corporation | $16.25 | 2025 | Zeposia |
| Upsher-Smith Laboratories LLC | $15.87 | 2021 | |
| Banner Life Sciences, LLC | $15.84 | 2022 | |
| Alnylam Pharmaceuticals INC. | $15.19 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harathi Bandaru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.